ALK and ROS1 testing on lung cancer cytologic samples: Perspectives.
about
The reproducibility of PD-L1 scoring in lung cancer: can the pathologists do better?Costs of ALK, ROS1, EGFR, and KRAS testing in non-small cell lung cancer: About different strategies in France.Reply to Costs of ALK, ROS1, EGFR, and KRAS testing in non-small cell lung cancer: About different strategies in France.Any Place for Immunohistochemistry within the Predictive Biomarkers of Treatment in Lung Cancer Patients?
P2860
ALK and ROS1 testing on lung cancer cytologic samples: Perspectives.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
ALK and ROS1 testing on lung cancer cytologic samples: Perspectives.
@en
type
label
ALK and ROS1 testing on lung cancer cytologic samples: Perspectives.
@en
prefLabel
ALK and ROS1 testing on lung cancer cytologic samples: Perspectives.
@en
P2093
P2860
P50
P356
P1433
P1476
ALK and ROS1 testing on lung cancer cytologic samples: Perspectives.
@en
P2093
Elena Vigliar
Francesco Pepe
Maria D Lozano
P2860
P304
P356
10.1002/CNCY.21899
P407
P577
2017-07-25T00:00:00Z